These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9400600)

  • 1. Insights into the interaction between tRNA and primer binding site from characterization of a unique HIV-1 virus which stably maintains dual PBS complementary to tRNA(Gly) and tRNA(His).
    Li Y; Zhang Z; Kang SM; Buescher JL; Morrow CD
    Virology; 1997 Nov; 238(2):273-82. PubMed ID: 9400600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
    Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
    Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
    Kang SM; Wakefield JK; Morrow CD
    Virology; 1996 Aug; 222(2):401-14. PubMed ID: 8806524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met).
    Kang SM; Zhang Z; Morrow CD
    J Virol; 1997 Jan; 71(1):207-17. PubMed ID: 8985340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).
    Wakefield JK; Kang SM; Morrow CD
    J Virol; 1996 Feb; 70(2):966-75. PubMed ID: 8551637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementarity between 3' terminal nucleotides of tRNA and primer binding site is a major determinant for selection of the tRNA primer used for initiation of HIV-1 reverse transcription.
    Yu Q; Morrow CD
    Virology; 1999 Feb; 254(1):160-8. PubMed ID: 9927583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA(His).
    Li Y; Zhang Z; Wakefield JK; Kang SM; Morrow CD
    J Virol; 1997 Sep; 71(9):6315-22. PubMed ID: 9261348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription.
    Zhang Z; Kang SM; Li Y; Morrow CD
    RNA; 1998 Apr; 4(4):394-406. PubMed ID: 9630246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations within the primer binding site of the human immunodeficiency virus type 1 define sequence requirements essential for reverse transcription.
    Wakefield JK; Morrow CD
    Virology; 1996 Jun; 220(2):290-8. PubMed ID: 8661380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of HIV type 1 proviral genomes that contain two distinct primer-binding sites.
    Li Y; Kang SM; Morrow CD
    AIDS Res Hum Retroviruses; 1997 Feb; 13(3):253-62. PubMed ID: 9115813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
    Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
    Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine leukemia virus with a primer-binding site complementary to tRNALys,3 adapts to select new tRNAs for replication following extended in vitro culture.
    Palmer MT; McPherson S; Morrow CD
    Virology; 2005 Mar; 333(2):337-48. PubMed ID: 15721366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic evidence of the interaction between tRNA(Lys,3) and U5 facilitating efficient initiation of reverse transcription by human immunodeficiency virus type 1.
    Zhang Z; Kang SM; Morrow CD
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):979-88. PubMed ID: 9686644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a human immunodeficiency virus type 1 that stably uses tRNALys1,2 rather than tRNALys,3 for initiation of reverse transcription.
    Kang SM; Zhang Z; Morrow CD
    Virology; 1999 Apr; 257(1):95-105. PubMed ID: 10208924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.
    Wakefield JK; Rhim H; Morrow CD
    J Virol; 1994 Mar; 68(3):1605-14. PubMed ID: 7508999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV type 1 that select tRNA(His) or tRNA(Lys1,2) as primers for reverse transcription exhibit different infectivities in peripheral blood mononuclear cells.
    Moore KL; Kosloff BR; Kelly NJ; Kirkman RL; Dupuy LC; McPherson S; Morrow CD
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):373-81. PubMed ID: 15157356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of a unique human immunodeficiency virus type 1 (HIV-1) with a primer binding site complementary to tRNAMet supports a role for U5-PBS stem-loop RNA structures in initiation of HIV-1 reverse transcription.
    Kang SM; Morrow CD
    J Virol; 1999 Mar; 73(3):1818-27. PubMed ID: 9971759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of murine leukemia virus replication complemented by yeast tRNA(Phe) reveals inherent preferences for the tRNA primer selected for reverse transcription.
    Palmer MT; Morrow CD
    Virology; 2004 Jul; 324(2):430-8. PubMed ID: 15207628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys).
    Wakefield JK; Wolf AG; Morrow CD
    J Virol; 1995 Oct; 69(10):6021-9. PubMed ID: 7545240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.